Liver safety parameters of ulipristal acetate for the treatment of uterine fibroids: a comprehensive review of the clinical development program
J Donnez, P Arriagada, M Marciniak… - Expert Opinion on Drug …, 2018 - Taylor & Francis
Introduction: Uterine fibroids are benign tumors within the uterine wall affecting women.
Ulipristal acetate 5 mg was first authorized in the European Union on 23 February 2012, with …
Ulipristal acetate 5 mg was first authorized in the European Union on 23 February 2012, with …
[引用][C] Liver safety parameters of ulipristal acetate for the treatment of uterine fibroids: a comprehensive review of the clinical development program
J Donnez, P Arriagada, M Marciniak… - Expert Opinion on Drug …, 2018 - cir.nii.ac.jp
Liver safety parameters of ulipristal acetate for the treatment of uterine fibroids: a comprehensive
review of the clinical development program | CiNii Research CiNii 国立情報学研究所 学術情報 …
review of the clinical development program | CiNii Research CiNii 国立情報学研究所 学術情報 …
Liver safety parameters of ulipristal acetate for the treatment of uterine fibroids: a comprehensive review of the clinical development program.
J Donnez, P Arriagada, M Marciniak… - Expert Opinion on Drug …, 2018 - europepmc.org
Uterine fibroids are benign tumors within the uterine wall affecting women. Ulipristal acetate
5 mg was first authorized in the European Union on 23 February 2012, with a post-marketing …
5 mg was first authorized in the European Union on 23 February 2012, with a post-marketing …
Liver safety parameters of ulipristal acetate for the treatment of uterine fibroids: a comprehensive review of the clinical development program
J Donnez, P Arriagada… - Expert opinion on …, 2018 - pubmed.ncbi.nlm.nih.gov
Introduction Uterine fibroids are benign tumors within the uterine wall affecting women.
Ulipristal acetate 5 mg was first authorized in the European Union on 23 February 2012, with …
Ulipristal acetate 5 mg was first authorized in the European Union on 23 February 2012, with …
Liver safety parameters of ulipristal acetate for the treatment of uterine fibroids: a comprehensive review of the clinical development program
J Donnez, A Pablo, D Larrey - Expert Opinion on Drug Safety, 2018 - hal.science
Introduction: Uterine fibroids are benign tumors within the uterine wall affecting women.
Ulipristal acetate 5 mg was first authorized in the European Union on 23 February 2012, with …
Ulipristal acetate 5 mg was first authorized in the European Union on 23 February 2012, with …
[PDF][PDF] Liver safety parameters of ulipristal acetate for the treatment of uterine fibroids: a comprehensive review of the clinical development program
J Donnez, P Arriagada, M Marciniak, D Larrey - 2018 - scholar.archive.org
Introduction: Uterine fibroids are benign tumors within the uterine wall affecting women.
Ulipristal acetate 5 mg was first authorized in the European Union on 23 February 2012, with …
Ulipristal acetate 5 mg was first authorized in the European Union on 23 February 2012, with …
[PDF][PDF] Liver safety parameters of ulipristal acetate for the treatment of uterine fibroids: a comprehensive review of the clinical development program
J Donnez, P Arriagada, M Marciniak, D Larrey - hal.science
Introduction: Uterine fibroids are benign tumors within the uterine wall affecting women.
Ulipristal acetate 5 mg was first authorized in the European Union on 23 February 2012, with …
Ulipristal acetate 5 mg was first authorized in the European Union on 23 February 2012, with …